Interferon-γ release assay for tuberculosis screening of healthcare workers at a Korean tertiary hospital

Scandinavian Journal of Infectious Diseases

Volumn 42, Issue 11-12, 2010, Pages 943-945

  Park, Hye Yun ^a   Jeon, Kyeongman ^a   Suh, Gee Young ^a   Kwon, O Jung ^a   Chung, Doo Ryeon ^b   Yoonchang, Sung Won ^c   Kang, Eun Suk ^c   Koh, Won Jung ^a  

^a Division of Critical Care   (United States)

^b Division of Infectious Diseases   (United States)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; ISONIAZID; RIFAMPICIN;

ADULT; ARTICLE; ASSAY; BCG VACCINATION; CLINICAL TRIAL; CYTOKINE RELEASE; EMPLOYMENT; FOLLOW UP; HEALTH CARE PERSONNEL; HOSPITAL INFECTION; HUMAN; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY; SCREENING; SOUTH KOREA; TERTIARY HEALTH CARE; THORAX RADIOGRAPHY; TREATMENT DURATION; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; FEMALE; HEALTH PERSONNEL; HOSPITALS; HUMANS; IMMUNOASSAY; INCIDENCE; INTERFERONS; ISONIAZID; MALE; MASS SCREENING; REPUBLIC OF KOREA; RIFAMPIN; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 78549296462     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2010.524658     Document Type: Article

References (12)

1. Menzies D, Joshi R, Pai M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis 2007;11:593-605.
2. Pai M, Zwerling A, Menzies D. Systematic review: T -cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;149:177-84.
3. Mazurek M, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 2010;59:1-25.
4. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, Kalantri S, et al. Serial testing of health care workers for tuberculosis using interferon- γ assay. Am J Respir Crit Care Med 2006;174:349-55.
5. Veerapathran A, Joshi R, Goswami K, Dogra S, Moodie EE, Reddy MV, et al. T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS One 2008;3:e1850.
6. Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, et al. Discrepancy between the tuberculin skin test and the wholeblood interferon γ assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005;293:2756-61.
7. Lee K, Han MK, Choi HR, Choi CM, Oh YM, Lee SD, et al. Annual incidence of latent tuberculosis infection among newly employed nurses at a tertiary care university hospital. Infect Control Hosp Epidemiol 2009;30:1218-22.
8. Chee CB, KhinMar KW, Gan SH, BarkhamT M, Pushparani M, Wang YT. Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specifi c antigens. Am J Respir Crit Care Med 2007;175:282-7.
9. Higuchi K, Harada N, Mori T. Interferon-γ responses after isoniazid chemotherapy for latent tuberculosis. Respirology 2008;13:468-72.
10. Lee SH, Lew WJ, Kim HJ, Lee HK, Lee YM, Cho CH, et al. Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak. Respir Med 2010; 104:448-53.
11. Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G, Lalvani A. Dynamic antigen-specifi c T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 2006;174:831-9.
12. Wilkinson KA, Kon OM, Newton SM, Meintjes G, Davidson RN, Pasvol G, et al. Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens. J Infect Dis 2006;193:354-9.